The inhibition of the sarcoplasmic calcium pump produced by agents which react with its lipid component: reserpine, prenylamine, chlorpromazine, imipramine.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors; D000255:Adenosine Triphosphate / Q000378:metabolism*; D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects*; D002118:Calcium / Q000378:metabolism*; D002746:Chlorpromazine / Q000494:pharmacology*; D003864:Depression, Chemical; D004721:Endoplasmic Reticulum / Q000187:drug effects / Q000378:metabolism*; D007099:Imipramine / Q000494:pharmacology*; D009132:Muscles / Q000166:cytology / Q000378:metabolism*; D010740:Phospholipases / Q000378:metabolism; D010743:Phospholipids / Q000378:metabolism; D011299:Prenylamine / Q000494:pharmacology*; D011817:Rabbits; D012110:Reserpine / Q000494:pharmacology*
D010743:Phospholipids; D012110:Reserpine; D000255:Adenosine Triphosphate; D010740:Phospholipases; D000251:Adenosine Triphosphatases; D011299:Prenylamine; D007099:Imipramine; D002118:Calcium; D002746:Chlorpromazine